J&J's psoriasis drug shows promise against Bristol's treatment in head-to-head study-February 2024-www.financetom.com

J&J's psoriasis drug shows promise against Bristol's treatment in head-to-head study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

J&J's psoriasis drug shows promise against Bristol's treatment in head-to-head study

Sep 17, 2025 7:40 AM

Sept 17 (Reuters) - Johnson & Johnson ( JNJ ) said on

Wednesday its experimental psoriasis drug showed superior skin

clearance compared to Bristol Myers Squibb's ( BMY ) Sotyktu in

two late-stage head-to-head trials.

Previous page： Onfolio Completes Acquisition of Eastern Standard Business Next page： Flag Ship Acquisition Signs Merger Deal With Great Rich Technologies

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Onfolio Completes Acquisition of Eastern Standard Business

Oct 22, 2024

09:37 AM EDT, 10/22/2024 (MT Newswires) -- Onfolio Holdings ( ONFO ) said Tuesday it has completed the transaction to acquire 70% of the assets of digital marketing services provider Eastern Standard for about $1.7 million. Onfolio ( ONFO ) said it issued $410,000 of series A preferred shares and two secured promissory notes amounting to about $1.3 million. Two...

Flag Ship Acquisition Signs Merger Deal With Great Rich Technologies

Oct 22, 2024

09:36 AM EDT, 10/22/2024 (MT Newswires) -- Flag Ship Acquisition ( FSHP ) said Tuesday it has signed an agreement with optoelectronic products' manufacturer Great Rich Technologies under which Flag Ship will be merged into the latter's GRT Merger Star unit. Financial terms weren't disclosed. Under the terms of the agreement, Flag Ship stockholders will get American depositary shares of...

Marlboro Maker Philip Morris Highlights Strong Q3 Performance On Higher Prices, Issues Upbeat Annual Forecast

Oct 22, 2024

On Tuesday, Philip Morris International Inc. ( PM ) stock is trading higher after the company reported better-than-expected third-quarter 2024 earnings. The Marlboro maker reported third-quarter revenue of $9.91 billion, up 8.4% year over year, beating the consensus of $9.69 billion. Net revenues increased by 11.6% on an organic basis, mainly reflecting a favorable pricing variance, primarily due to higher combustible...

Grifols Teams Up With BARDA to Test Treatment for Eye Injuries Caused by Mustard Gas

Oct 22, 2024

09:32 AM EDT, 10/22/2024 (MT Newswires) -- Grifols ( GRFS ) said Tuesday it has launched a partnership with the Biomedical Advanced Research and Development Authority, or BARDA, to assess investigational ocular surface immunoglobulin eye drops to treat damage from exposure to sulfur mustard, a chemical warfare agent. The company said BARDA is part of the US Department of Health...